Prot# Cx601-0303: A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem cells (eASC), for the treatment of complex

Project: Research project

Project Details

StatusFinished
Effective start/end date7/30/21 → 7/30/24

Funding

  • Parexel ((OE)Prot# Cx601- // (OE)Prot# Cx601-)
  • TiGenix, S.A.U. ((OE)Prot# Cx601- // (OE)Prot# Cx601-)